361 related articles for article (PubMed ID: 33139601)
21. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
[TBL] [Abstract][Full Text] [Related]
22. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
23. Novel perspectives on therapeutic modulation of the gut microbiota.
McCarville JL; Caminero A; Verdu EF
Therap Adv Gastroenterol; 2016 Jul; 9(4):580-93. PubMed ID: 27366225
[TBL] [Abstract][Full Text] [Related]
24. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
[TBL] [Abstract][Full Text] [Related]
25. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
[TBL] [Abstract][Full Text] [Related]
26. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
27. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
Berg D; Clemente JC; Colombel JF
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):781-95. PubMed ID: 25665875
[TBL] [Abstract][Full Text] [Related]
28. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
Quigley EM
Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
[TBL] [Abstract][Full Text] [Related]
29. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
Schulberg J; De Cruz P
Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
[TBL] [Abstract][Full Text] [Related]
30. The microbiota in inflammatory bowel disease: current and therapeutic insights.
Lane ER; Zisman TL; Suskind DL
J Inflamm Res; 2017; 10():63-73. PubMed ID: 28652796
[TBL] [Abstract][Full Text] [Related]
31. Dysbiosis in Functional Bowel Disorders.
Enck P; Mazurak N
Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiota and inflammatory bowel disease: so far so gut!
Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
[TBL] [Abstract][Full Text] [Related]
33. Novel cancer therapy targeting microbiome.
Nagano T; Otoshi T; Hazama D; Kiriu T; Umezawa K; Katsurada N; Nishimura Y
Onco Targets Ther; 2019; 12():3619-3624. PubMed ID: 31190864
[TBL] [Abstract][Full Text] [Related]
34. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
Doré J; Multon MC; Béhier JM;
Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
[TBL] [Abstract][Full Text] [Related]
35. The gut microbiome and irritable bowel syndrome: State of art review.
Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
[TBL] [Abstract][Full Text] [Related]
36. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota and allogeneic transplantation.
Wang W; Xu S; Ren Z; Jiang J; Zheng S
J Transl Med; 2015 Aug; 13():275. PubMed ID: 26298517
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
Konturek PC; Zopf Y
MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
[TBL] [Abstract][Full Text] [Related]
39. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies.
West CE; Renz H; Jenmalm MC; Kozyrskyj AL; Allen KJ; Vuillermin P; Prescott SL;
J Allergy Clin Immunol; 2015 Jan; 135(1):3-13; quiz 14. PubMed ID: 25567038
[TBL] [Abstract][Full Text] [Related]
40. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?
Ooi SL; Correa D; Pak SC
Complement Ther Med; 2019 Apr; 43():73-80. PubMed ID: 30935559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
